IR@PKUHSC  > 北京大学药学院
学科主题药学
Three anti-tumor saponins from Albizia julibrissin
Zheng, L; Zheng, J; Zhao, YY; Wang, B; Wu, LJ; Liang, H
关键词Albizia Julibrissin Julibroside j(29) Julibroside j(30) Juliborside j(31) Anti-tumor Activity
刊名BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
2006-05-15
DOI10.1016/j.bmcl.2006.02.009
16期:10页:2765-2768
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Chemistry, Medicinal ; Chemistry, Organic
研究领域[WOS]Pharmacology & Pharmacy ; Chemistry
关键词[WOS]GLYCOSIDES
英文摘要

Three new triterpenoid saponins, julibroside J(29) (1), julibroside J(30) (2), and julibroside J(31) (3), were isolated from the stem bark of Albizia julibrissin Durazz. (Leguminosae) by using chromatographic method. Their structures were established by spectroscopic methods. Compounds 1, 2, and 3 displayed significant anti-tumor activities in vitro against PC-3M-1E8, HeLa, and MDA-MB-435 cancer cell lines at 10 mu M assayed by SRB and MTT methods. (C) 2006 Elsevier Ltd. All rights reserved.

语种英语
WOS记录号WOS:000236839700041
引用统计
被引频次:46[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/53434
专题北京大学药学院
作者单位1.Peking Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Beijing 100083, Peoples R China
2.Shanyang Pharmaceut Univ, Dept Nat Prod Chem, Shenyang 110016, Peoples R China
推荐引用方式
GB/T 7714
Zheng, L,Zheng, J,Zhao, YY,et al. Three anti-tumor saponins from Albizia julibrissin[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2006,16(10):2765-2768.
APA Zheng, L,Zheng, J,Zhao, YY,Wang, B,Wu, LJ,&Liang, H.(2006).Three anti-tumor saponins from Albizia julibrissin.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,16(10),2765-2768.
MLA Zheng, L,et al."Three anti-tumor saponins from Albizia julibrissin".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 16.10(2006):2765-2768.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zheng, L]的文章
[Zheng, J]的文章
[Zhao, YY]的文章
百度学术
百度学术中相似的文章
[Zheng, L]的文章
[Zheng, J]的文章
[Zhao, YY]的文章
必应学术
必应学术中相似的文章
[Zheng, L]的文章
[Zheng, J]的文章
[Zhao, YY]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。